Literature DB >> 2574360

Restriction of dietary protein and progression of renal failure in diabetic nephropathy.

J D Walker1, J J Bending, R A Dodds, M B Mattock, T J Murrells, H Keen, G C Viberti.   

Abstract

In a study of the effect of a low-protein diet on the progression of renal disease 19 insulin-dependent diabetic patients with persistent clinical proteinuria were observed for 12-39 (mean 29) months while they were on a normal-protein diet (1.13 [0.06] g/kg per day), then for 12-49 (mean 33) months on a low-protein diet (0.67 [0.03] g/kg per day). The low-protein diet had no adverse effect on nutrition or glycosylated haemoglobin concentration. Mean supine blood pressure (BP) fell slightly on the low-protein diet and was probably due to the start or modification of antihypertensive medication in 9 patients. The mean rate of decline in glomerular filtration rate fell from 0.61 (SEM 0.14) ml/min per month with the normal-protein diet to 0.14 (0.08) with the low-protein diet, and this effect remained highly significant after adjustment for blood pressure, energy intake, and glycosylated haemoglobin. The rise in the fractional clearance of albumin during a normal-protein diet stopped with the low-protein diet, and there was a significant fall in albumin excretion from 467 (95% CI 234-895) micrograms/24 h on the normal-protein to 340 (138-719) on the low-protein diet. Thus, a low-protein diet, with its reduction in protein and possibly other dietary components such as phosphate or fat, seems to retard the rate of decline of glomerular filtration rate in diabetic nephropathy independently of blood pressure changes and glycaemic control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574360     DOI: 10.1016/s0140-6736(89)92032-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 2.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 4.  Mechanisms of diabetic renal and cardiovascular disease.

Authors:  G C Viberti
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 5.  Effect of low-protein diet on renal function: are there definite conclusions from adult studies?

Authors:  N Gretz; J J Lasserre; A Hocker; M Strauch
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

Review 6.  Low-protein diet for diabetic nephropathy.

Authors:  Toshiki Otoda; Keizo Kanasaki; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.

Authors:  R Malhotra; K L Cavanaugh; W J Blot; T A Ikizler; L Lipworth; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-07-21       Impact factor: 4.222

8.  Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Pomerleau; M Verdy; D R Garrel; M H Nadeau
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

9.  Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.

Authors:  Theodoros Eleftheriadis; Konstantina Tsogka; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

Review 10.  Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?

Authors:  Wei X Lu; Jay Lakkis; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.